These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 33525792)

  • 1. Metabolic engineering of mammalian cells to produce heparan sulfates.
    Thacker BE; Sharfstein ST
    Emerg Top Life Sci; 2018 Oct; 2(3):443-452. PubMed ID: 33525792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant Heparin-New Opportunities.
    Glass CA
    Front Med (Lausanne); 2018; 5():341. PubMed ID: 30564580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward a bioengineered heparin: challenges and strategies for metabolic engineering of mammalian cells.
    Baik JY; Wang CL; Yang B; Linhardt RJ; Sharfstein S
    Bioengineered; 2012; 3(4):227-31. PubMed ID: 22714556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tunicate Heparan Sulfate Enriched in 2-Sulfated β-Glucuronic Acid: Structure, Anticoagulant Activity, and Inhibitory Effect on the Binding of Human Colon Adenocarcinoma Cells to Immobilized P-Selectin.
    Abreu WS; Soares PAG; Motta JM; Kozlowski EO; Teixeira FCOB; Soares MA; Borsig L; Mourão PAS; Pavão MSG
    Mar Drugs; 2019 Jun; 17(6):. PubMed ID: 31212795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cooperation of binding sites at the hydrophilic domain of cell-surface sulfatase Sulf1 allows for dynamic interaction of the enzyme with its substrate heparan sulfate.
    Milz F; Harder A; Neuhaus P; Breitkreuz-Korff O; Walhorn V; Lübke T; Anselmetti D; Dierks T
    Biochim Biophys Acta; 2013 Nov; 1830(11):5287-98. PubMed ID: 23891937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulant heparan sulfate: structural specificity and biosynthesis.
    Liu J; Pedersen LC
    Appl Microbiol Biotechnol; 2007 Feb; 74(2):263-72. PubMed ID: 17131147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of biologically active heparan sulfate and heparin using an enzyme-based approach.
    Peterson S; Frick A; Liu J
    Nat Prod Rep; 2009 May; 26(5):610-27. PubMed ID: 19387498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-Activity Relationships of Bioengineered Heparin/Heparan Sulfates Produced in Different Bioreactors.
    Kim HN; Whitelock JM; Lord MS
    Molecules; 2017 May; 22(5):. PubMed ID: 28505124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies to vascular heparan sulfate proteoglycan in systemic lupus erythematosus react with endothelial cells and inhibit the formation of thrombin-antithrombin III complexes.
    Shibata S; Sasaki T; Harpel P; Fillit H
    Clin Immunol Immunopathol; 1994 Feb; 70(2):114-23. PubMed ID: 8299226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparan sulfates and heparan sulfate binding proteins in sepsis.
    Liao YE; Liu J; Arnold K
    Front Mol Biosci; 2023; 10():1146685. PubMed ID: 36865384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of bioprocess conditions improves production of a CHO cell-derived, bioengineered heparin.
    Baik JY; Dahodwala H; Oduah E; Talman L; Gemmill TR; Gasimli L; Datta P; Yang B; Li G; Zhang F; Li L; Linhardt RJ; Campbell AM; Gorfien SF; Sharfstein ST
    Biotechnol J; 2015 Jul; 10(7):1067-81. PubMed ID: 26037948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-based assay for N-deacetylase activity of heparan sulfate/heparin N-deacetylase/N-sulfotransferase (NDST): novel characteristics of NDST-1 and -2.
    van den Born J; Pikas DS; Pisa BJ; Eriksson I; Kjellen L; Berden JH
    Glycobiology; 2003 Jan; 13(1):1-10. PubMed ID: 12634318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A syngeneic monoclonal antibody to murine Meth-A sarcoma (HepSS-1) recognizes heparan sulfate glycosaminoglycan (HS-GAG): cell density and transformation dependent alteration in cell surface HS-GAG defined by HepSS-1.
    Kure S; Yoshie O
    J Immunol; 1986 Dec; 137(12):3900-8. PubMed ID: 2431047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and anticoagulant properties of sulfated glycosaminoglycans from primitive Chordates.
    Pavão MS
    An Acad Bras Cienc; 2002 Mar; 74(1):105-12. PubMed ID: 11960179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Passage of classical swine fever virus in cultured swine kidney cells selects virus variants that bind to heparan sulfate due to a single amino acid change in envelope protein E(rns).
    Hulst MM; van Gennip HG; Moormann RJ
    J Virol; 2000 Oct; 74(20):9553-61. PubMed ID: 11000226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human herpesvirus 8 envelope-associated glycoprotein B interacts with heparan sulfate-like moieties.
    Akula SM; Pramod NP; Wang FZ; Chandran B
    Virology; 2001 Jun; 284(2):235-49. PubMed ID: 11384223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relevance of glycosaminoglycan sulfates to Apo E induced lipid uptake by hepatocyte monolayers.
    Oswald B; Shelburne F; Landis B; Linker A; Quarfordt S
    Biochem Biophys Res Commun; 1986 Nov; 141(1):158-64. PubMed ID: 2948501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparan sulfate and development: differential roles of the N-acetylglucosamine N-deacetylase/N-sulfotransferase isozymes.
    Grobe K; Ledin J; Ringvall M; Holmborn K; Forsberg E; Esko JD; Kjellén L
    Biochim Biophys Acta; 2002 Dec; 1573(3):209-15. PubMed ID: 12417402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin-like heparan sulfate from rabbit cartilage.
    Parra A; Veraldi N; Locatelli M; Fini M; Martini L; Torri G; Sangiorgi L; Bisio A
    Glycobiology; 2012 Feb; 22(2):248-57. PubMed ID: 21933839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dromedary glycosaminoglycans: molecular characterization of camel lung and liver heparan sulfate.
    Warda M; Linhardt RJ
    Comp Biochem Physiol B Biochem Mol Biol; 2006 Jan; 143(1):37-43. PubMed ID: 16298150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.